Elevance Health, Inc. (ELV) income statement
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$400.84−33.09 (-7.63%)
Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –
Elevance Health, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 89.0%
- Operating margin
- 2.7%
- Net margin
- 2.5%
- Return on equity, FY2025
- 13.3%
Financial strength
- Current ratio
- 1.47
- Debt to equity
- 0.69
- Debt to assets
- 24.1%
- Cash to current liabilities
- 22.2%
Valuation
- P/E ratio
- 17.1
- Price to sales
- 0.43
- Price to book
- 1.94
- Dividend yield
- –
See a number that looks wrong?